Search

everythinglearnresearchcommunity

for

Search:↓

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Both estrogens and androgens are important for health in both males and females.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Hormonal therapies effectively treat acne and improve quality of life.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Finasteride treats hair loss but may cause low libido, erectile issues, and depression.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

A young woman's rare ovarian tumor was successfully removed, improving her hormonal symptoms.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Testosterone significantly affects urination differences between male and female mice.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

A new mutation in the DCAF17 gene was found to cause Woodhouse-Sakati syndrome in a large family.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Minoxidil and finasteride are effective for treating hair loss, with dutasteride showing potential but with side effects.

The document explains how male reproductive hormones work and affect the body.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Improved finasteride formula allows slow, sustained release and better absorption for patients.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.